Jeffrey Goshe, MD

216.444.0845

Jeffrey Goshe, MD

Appointed: 2011

Jeffrey Goshe, MD
Department: Ophthalmology
Location: Cleveland Clinic Main Campus
Mail Code i32
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.0845
WorkFax:216.445.2226
Surgeon:
Yes
Treats:
Adults Only

Biographical Sketch

Jeffrey Goshe, MD, joined Cleveland Clinic Cole Eye Institute after completing a fellowship in Cornea and External Disease at the Devers Eye Institute in Portland, Oregon. During his fellowship, Dr. Goshe trained with Mark A. Terry, MD, a world-renowned leader in cornea transplantation.

Dr. Goshe is actively researching corneal transplantation techniques and has published peer-reviewed journal articles on Descemet's Stripping Automated Endothelial Keratoplasty (DSAEK) and Deep Anterior Lamellar Keratoplasty (DALK). He completed his ophthalmology residency at Cole Eye Institute, where he was elected Chief Resident, served on the Resident Education Committee, and won the Best Resident Paper/Presentation Award at the 2009 Cole Eye Institute Annual Research & Alumni Meeting. Dr. Goshe graduated from Case Western Reserve University School of Medicine, where he was inducted into Alpha Omega Alpha.

Education & Fellowships

Fellowship - Devers Eye Institute
Ophthalmology Cornea External Disease
Portland, OR
2011
Residency - Cleveland Clinic
Ophthalmology
Cleveland, OH USA
2010
Internship - Akron City Hospital
Internal Medicine
Akron, OH USA
2007
Medical School - Case Western Reserve University School of Medicine
Cleveland, OH USA
2006
Undergraduate - Case Western Reserve University
Cleveland, OH USA
2002

Certifications

  • Ophthalmology

Treatment & Services

  • Cataract Surgery
  • Corneal Surgery
  • Corneal Transplant
  • Ophthalmic Reconstructive Surgery
  • Ophthalmic Surgery

Specialty in Diseases and Conditions

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 9/10/2013, Dr. Goshe has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • English
Cleveland Clinic Mobile Site